JANUMET 50 mg/1

JANUMET 50 mg/1 combines sitagliptin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

JANUMET 50 mg/1 is primarily used to manage type 2 diabetes in adults. It works by improving insulin sensitivity and reducing glucose production in the liver. This combination medication is often prescribed alongside diet and exercise to help control blood sugar levels effectively.

Common effects of JANUMET 50 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience headaches or dizziness. These effects are generally mild and temporary as the body adjusts to the medication.

JANUMET 50 mg/1 should be used with caution in individuals with kidney issues or a history of pancreatitis. It is important to follow the advice of a healthcare provider regarding monitoring and potential adjustments to the treatment plan. Always inform your healthcare provider about any other medications you are taking.

JANUMET 50 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. It is advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication.